Ovzon AB (publ) ("Ovzon" or the "Company") announced on 13 April 2021 that the listing committee of Nasdaq Stockholm has approved the listing application for admission to trading of the Company's shares on Nasdaq Stockholm (main market). Ovzon has in connection with the listing transfer prepared a prospectus which today has been approved by the Swedish Financial Supervisory Authority ("SFSA")
(Sw. Finansinspektionen) and has been published on the Company's web page, www.ovzon.com. In the prospectus, due to regulatory requirements, updated financial information can be found as of 28 February 2021 attributable to the Company's equity and liabilities and net indebtedness.
Publication of the prospectus
For complete information about the listing transfer, please see the prospectus (only Swedish version availible) that has been prepared by the Company and that today has been approved by the SFSA. The prospectus is available on the Company's web page, (www.ovzon.com), and will also, in a few days, be available on the SFSA's web page, (https://fi.se/sv/vara-register/prospektregistret/).
The prospectus has been prepared in accordance with the Regulation (EU) 2017/1129 (the "Prospectus Regulation"). The prospectus has been approved by the SFSA, which is the Swedish competent authority in accordance with the Prospectus Regulation, in accordance with article 20 in the Prospectus Regulation. The SFSA only approves the prospectus as meeting the standards of completeness, comprehensibility and consistency imposed by the Prospectus Regulation. The approval should not be considered as an endorsement of Ovzon or as an endorsement of the quality of the shares that are the subject of the prospectus and does not indicate that the SFSA guarantees that the facts in the prospectus are correct or complete. Investors should make their own assessment as to the suitability of investing in the Company's shares.
Updated financial information regarding equity and liabilities and net indebtedness
The following tables are found on p. 41 and 42 in the prospectus.
Equity and liabilities
MSEK 28 februari 2021
Total current debt -
Total Non-Current debt 5.3
Share capital 4.6
Other contributed capital 1 560.6
Other reserves 1.0
Profit/loss (as of) 31 december 2020 -288.6
Total shareholder's equity 1277.6
MSEK 28 februari 2021
A - Cash -
B - Cash equivalent[[]] 99.2
C - Trading securities -
D - Liquidity (A+B+C) 99.2
E - Current Financial Receivable -
F - Current Bank Debt -
G - Current portion of non-current debt -
H - Other current financial debt -
I - Current Financial Debt (F+G+H) -
J - Net Current Financial Indebtedness (I - E - D) -99.2
K - Non-current bank loans -
L - Bonds Issued -
M - Other non-current loans -
N - Non-current Financial Indebtedness (K+L+M) -
O - Net Financial Indebtedness (J+N) -99.2
The liability is linked to leasing for accounting purposes in accordance with IFRS 16, which is reported with interest which, however, does not have a cash flow impact.
 Cash and cash equivalents consist of cash and bank balances.
About the listing transfer
The trading in the Company's shares on Nasdaq Stockholm is expected to commence on Tuesday April 20, 2021, and the last day of trading on Nasdaq First North Growth Market is expected to be on Monday 19 April. The shares will be traded unchanged with ticker (Ovzon) and ISIN code (SE0010948711). No offer or issue of new shares will be made in connection with the Company's shares being admitted to trading on Nasdaq Stockholm. Shareholders in Ovzon do not need to take any actions in connection with the list transfer.
Baker McKenzie is the Company's legal adviser in connection with the admission to trading of the Company's shares on Nasdaq Stockholm.
FNCA Sweden AB, +46(0)8-528 00 399, firstname.lastname@example.org,is the Company's Certified Adviser on Nasdaq First North Premier Growth Market.
For further information please contact;
Magnus René, CEO
+1 781 266 6957
Johan Brandt, CFO
+46 703 69 33 00
This information was distributed by Cision http://www.cisionwire.se/